The agreement paves the way for technology transfer and potential commercialisation of a promising new vaccine candidate, ...

A promising tuberculosis vaccine candidate, developed by ILS Bhubaneswar and IIT Bhubaneswar, has been transferred to ...

A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

Wealthier consumptive patients had long been directed to salubrious locations such as seaside resorts or spa towns to escape ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS), along with the ...

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, claiming 1.23 million lives in 2024 alone, as reported by the WHO. Ending the TB epidemic by 2030 is a key global health ...

Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.

IIT Bhubaneswar and ILS transferred novel TB vaccine technology to TechInvention, facilitated by NRDC, to combat tuberculosis ...

In a significant breakthrough, the Institute of Life Sciences (ILS), Bhubaneswar has developed a next-generation subunit ...

Given that many tiny nodules were found, these are unlikely to be lung cancer, which is generally only a single nodule ...

In several states across India, COPD is now emerging as a major cause of death, sometimes even surpassing heart disease in ...

A joint study by various researchers from government and other organisations has revealed that evidence from India shapes National and Global policies on Nutrition and Tuberculosis (TB).